Over the past 12 months, 4 insiders at Nuvectis Pharma, Inc. filed 6 open-market SEC Form 4 transactions on NVCT: 6 purchases worth $1.1M and 0 sales worth $0. Insiders have been net buyers over this period. The most recent filing was on Nov 5, 25.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 5, 25 | Ron BentsurChairman & CEO | BUY | 5.0K | $5.72 | $29K |
| Nov 5, 25 | Matthew L. KaplanDirector | BUY | 11.0K | $5.84 | $64K |
| Nov 5, 25 | Juan SanchezDirector | BUY | 13.0K | $5.79 | $75K |
| Oct 27, 25 | Marlio Charles MosseriTenPercentOwner | BUY | 72.8K | $6.28 | $457K |
| Oct 24, 25 | Marlio Charles MosseriTenPercentOwner | BUY | 35.0K | $6.15 | $215K |
| Oct 23, 25 | Marlio Charles MosseriTenPercentOwner | BUY | 46.9K | $6.06 | $284K |
| Jun 20, 25 | Marlio Charles MosseriTenPercentOwner | BUY | 5.6K | $7.99 | $45K |
| Jun 18, 25 | Marlio Charles MosseriTenPercentOwner | BUY | 28.0K | $8.05 | $226K |
| Jun 17, 25 | Marlio Charles MosseriTenPercentOwner | BUY | 5.4K | $8.11 | $44K |
| May 12, 25 | Marlio Charles MosseriTenPercentOwner | BUY | 21.2K | $8.11 | $172K |
| May 9, 25 | Marlio Charles MosseriTenPercentOwner | BUY | 9.8K | $8.98 | $88K |
| May 8, 25 | Marlio Charles MosseriTenPercentOwner | BUY | 2.4K | $8.97 | $22K |
| May 7, 25 | Marlio Charles MosseriTenPercentOwner | BUY | 9.6K | $8.64 | $83K |
| May 6, 25 | Marlio Charles MosseriTenPercentOwner | BUY | 10.1K | $8.64 | $87K |
| Feb 7, 25 | Marlio Charles MosseriTenPercentOwner | BUY | 240.0K | $5.00 | $1.2M |
| Dec 24, 24 | Ron BentsurChairman & CEO | BUY | 4.5K | $4.65 | $21K |
| Dec 13, 24 | Marlio Charles MosseriTenPercentOwner | BUY | 17.0K | $4.70 | $80K |
| Dec 12, 24 | Marlio Charles MosseriTenPercentOwner | BUY | 32.1K | $4.64 | $149K |
| Nov 19, 24 | Enrique PoradosuChief Science & Business Off | BUY | 2.0K | $4.99 | $10K |
| Nov 15, 24 | Ron BentsurChairman & CEO | BUY | 20.0K | $4.92 | $98K |
| Nov 7, 24 | Michael J. CarsonVice President, Finance | SELL | 2.8K | $8.16 | $22K |
| May 14, 24 | Ron BentsurChairman & CEO | BUY | 1.9K | $6.74 | $13K |
| May 10, 24 | Ron BentsurChairman & CEO | BUY | 2.0K | $6.40 | $13K |
| May 10, 24 | Enrique PoradosuChief Science & Business Off | BUY | 500 | $6.29 | $3K |
| May 10, 24 | Shay ShemeshChief Dev. & Ops. Officer | BUY | 1.1K | $6.32 | $7K |
| Mar 18, 24 | Ron BentsurChairman & CEO | BUY | 5.0K | $10.29 | $51K |
| Oct 10, 23 | Ron BentsurChairman & CEO | BUY | 640 | $11.08 | $7K |
| Oct 9, 23 | Ron BentsurChairman & CEO | BUY | 830 | $11.19 | $9K |
| Oct 6, 23 | Ron BentsurChairman & CEO | BUY | 250 | $11.27 | $3K |
| Oct 5, 23 | Ron BentsurChairman & CEO | BUY | 1.4K | $11.09 | $16K |
| Oct 4, 23 | Ron BentsurChairman & CEO | BUY | 1.8K | $10.95 | $20K |
| Aug 16, 23 | Ron BentsurChairman & CEO | BUY | 115 | $15.15 | $2K |
| Aug 15, 23 | Ron BentsurChairman & CEO | BUY | 235 | $14.34 | $3K |
| Aug 11, 23 | Ron BentsurChairman & CEO | BUY | 180 | $14.66 | $3K |
| Aug 8, 23 | Ron BentsurChairman & CEO | BUY | 120 | $14.83 | $2K |
| Jul 31, 23 | Marlio Charles MosseriTenPercentOwner | BUY | 860 | $13.88 | $12K |
| Jul 28, 23 | Marlio Charles MosseriTenPercentOwner | BUY | 2.6K | $13.91 | $36K |
| Jul 27, 23 | Marlio Charles MosseriTenPercentOwner | BUY | 1.6K | $13.98 | $22K |
| Jul 26, 23 | Marlio Charles MosseriTenPercentOwner | BUY | 10.0K | $13.97 | $140K |
| Jul 21, 23 | Ron BentsurChairman & CEO | BUY | 225 | $14.85 | $3K |
| Jul 21, 23 | Marlio Charles MosseriTenPercentOwner | BUY | 2.8K | $14.61 | $42K |
| Jul 20, 23 | Ron BentsurChairman & CEO | BUY | 110 | $15.06 | $2K |
| Jul 20, 23 | Marlio Charles MosseriTenPercentOwner | BUY | 5.4K | $14.40 | $78K |
| Jul 19, 23 | Ron BentsurChairman & CEO | BUY | 200 | $14.33 | $3K |
| Jul 19, 23 | Marlio Charles MosseriTenPercentOwner | BUY | 8.0K | $14.84 | $119K |
| Jul 18, 23 | Marlio Charles MosseriTenPercentOwner | BUY | 9.1K | $14.84 | $136K |
| Jul 14, 23 | Ron BentsurChairman & CEO | BUY | 150 | $15.03 | $2K |
| Jul 12, 23 | Marlio Charles MosseriTenPercentOwner | BUY | 3.3K | $15.09 | $50K |
| Jul 11, 23 | Marlio Charles MosseriTenPercentOwner | BUY | 10.0K | $15.36 | $154K |
| Jul 7, 23 | Ron BentsurChairman & CEO | BUY | 110 | $16.19 | $2K |
Over the past 12 months, insiders at Nuvectis Pharma, Inc. filed 6 open-market purchases worth $1.1M and 0 sales worth $0 on NVCT, which makes them net buyers over the period. The most recent Form 4 was filed on Nov 5, 25.
The largest recent open-market NVCT insider purchase in our data was $1.2M by Marlio Charles Mosseri, TenPercentOwner, filed on Feb 7, 25.
4 different insiders at Nuvectis Pharma, Inc. filed open-market SEC Form 4 transactions on NVCT over the last 12 months.
InsiderTape plots every NVCT insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every Nuvectis Pharma, Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →